DEXCOM INC (DXCM) Stock Fundamental Analysis
USA - NASDAQ:DXCM - US2521311074 - Common Stock
66.63 USD
+0.3 (+0.45%)
Overall DXCM gets a fundamental rating of 6 out of 10. We evaluated DXCM against 191 industry peers in the Health Care Equipment & Supplies industry. While DXCM has a great profitability rating, there are some minor concerns on its financial health. DXCM is growing strongly while it is still valued neutral. This is a good combination! This makes DXCM very considerable for growth investing!
1. Profitability
1.1 Basic Checks
DXCM had positive earnings in the past year.
DXCM had a positive operating cash flow in the past year.
DXCM had positive earnings in each of the past 5 years.
Each year in the past 5 years DXCM had a positive operating cash flow.
1.2 Ratios
The Return On Assets of DXCM (7.80%) is better than 91.10% of its industry peers.
DXCM has a better Return On Equity (22.21%) than 94.24% of its industry peers.
With an excellent Return On Invested Capital value of 14.52%, DXCM belongs to the best of the industry, outperforming 94.24% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for DXCM is above the industry average of 8.89%.
The 3 year average ROIC (11.25%) for DXCM is below the current ROIC(14.52%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.8% | ||
| ROE | 22.21% | ||
| ROIC | 14.52% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
1.3 Margins
DXCM has a better Profit Margin (13.29%) than 89.53% of its industry peers.
In the last couple of years the Profit Margin of DXCM has grown nicely.
The Operating Margin of DXCM (17.22%) is better than 87.43% of its industry peers.
In the last couple of years the Operating Margin of DXCM has grown nicely.
DXCM has a better Gross Margin (60.01%) than 60.21% of its industry peers.
In the last couple of years the Gross Margin of DXCM has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.22% | ||
| PM (TTM) | 13.29% | ||
| GM | 60.01% |
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), DXCM is creating value.
The number of shares outstanding for DXCM has been increased compared to 1 year ago.
The number of shares outstanding for DXCM has been increased compared to 5 years ago.
DXCM has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 4.85 indicates that DXCM is not in any danger for bankruptcy at the moment.
DXCM has a Altman-Z score of 4.85. This is in the better half of the industry: DXCM outperforms 79.06% of its industry peers.
The Debt to FCF ratio of DXCM is 4.38, which is a neutral value as it means it would take DXCM, 4.38 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 4.38, DXCM belongs to the best of the industry, outperforming 80.63% of the companies in the same industry.
A Debt/Equity ratio of 0.50 indicates that DXCM is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.50, DXCM is in line with its industry, outperforming 41.88% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 4.38 | ||
| Altman-Z | 4.85 |
ROIC/WACC1.82
WACC7.96%
2.3 Liquidity
DXCM has a Current Ratio of 1.52. This is a normal value and indicates that DXCM is financially healthy and should not expect problems in meeting its short term obligations.
DXCM has a worse Current ratio (1.52) than 73.82% of its industry peers.
DXCM has a Quick Ratio of 1.35. This is a normal value and indicates that DXCM is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.35, DXCM is doing worse than 64.40% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.52 | ||
| Quick Ratio | 1.35 |
3. Growth
3.1 Past
DXCM shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.86%.
The Earnings Per Share has been growing by 29.25% on average over the past years. This is a very strong growth
DXCM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.30%.
The Revenue has been growing by 22.27% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-2.86%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%11.63%
Revenue 1Y (TTM)9.3%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%15.21%
3.2 Future
Based on estimates for the next years, DXCM will show a very strong growth in Earnings Per Share. The EPS will grow by 22.60% on average per year.
DXCM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.90% yearly.
EPS Next Y26.84%
EPS Next 2Y26.2%
EPS Next 3Y24.65%
EPS Next 5Y22.6%
Revenue Next Year14.99%
Revenue Next 2Y15.17%
Revenue Next 3Y14.81%
Revenue Next 5Y13.9%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
DXCM is valuated quite expensively with a Price/Earnings ratio of 39.19.
DXCM's Price/Earnings ratio is a bit cheaper when compared to the industry. DXCM is cheaper than 69.63% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.29, DXCM is valued a bit more expensive.
With a Price/Forward Earnings ratio of 25.36, DXCM can be considered very expensive at the moment.
DXCM's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. DXCM is cheaper than 74.35% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of DXCM to the average of the S&P500 Index (22.85), we can say DXCM is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.19 | ||
| Fwd PE | 25.36 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DXCM indicates a somewhat cheap valuation: DXCM is cheaper than 72.77% of the companies listed in the same industry.
76.96% of the companies in the same industry are more expensive than DXCM, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 45.78 | ||
| EV/EBITDA | 24.38 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of DXCM may justify a higher PE ratio.
A more expensive valuation may be justified as DXCM's earnings are expected to grow with 24.65% in the coming years.
PEG (NY)1.46
PEG (5Y)1.34
EPS Next 2Y26.2%
EPS Next 3Y24.65%
5. Dividend
5.1 Amount
DXCM does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:DXCM (10/17/2025, 3:15:57 PM)
66.63
+0.3 (+0.45%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners97.73%
Inst Owner Change-0.24%
Ins Owners0.19%
Ins Owner Change2.47%
Market Cap26.13B
Analysts84.57
Price Target104.5 (56.84%)
Short Float %3.37%
Short Ratio2.66
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.34%
Min EPS beat(2)-4.09%
Max EPS beat(2)6.77%
EPS beat(4)2
Avg EPS beat(4)-1.87%
Min EPS beat(4)-11.66%
Max EPS beat(4)6.77%
EPS beat(8)6
Avg EPS beat(8)9.43%
EPS beat(12)10
Avg EPS beat(12)14.38%
EPS beat(16)11
Avg EPS beat(16)8.49%
Revenue beat(2)1
Avg Revenue beat(2)0.34%
Min Revenue beat(2)-0.19%
Max Revenue beat(2)0.88%
Revenue beat(4)1
Avg Revenue beat(4)-0.54%
Min Revenue beat(4)-1.66%
Max Revenue beat(4)0.88%
Revenue beat(8)2
Avg Revenue beat(8)-0.78%
Revenue beat(12)5
Avg Revenue beat(12)-0.39%
Revenue beat(16)6
Avg Revenue beat(16)-0.42%
PT rev (1m)-0.85%
PT rev (3m)2.64%
EPS NQ rev (1m)0.12%
EPS NQ rev (3m)-0.03%
EPS NY rev (1m)0.14%
EPS NY rev (3m)1.07%
Revenue NQ rev (1m)0.08%
Revenue NQ rev (3m)0.67%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)0.23%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.19 | ||
| Fwd PE | 25.36 | ||
| P/S | 6.08 | ||
| P/FCF | 45.78 | ||
| P/OCF | 26.46 | ||
| P/B | 10.15 | ||
| P/tB | 10.61 | ||
| EV/EBITDA | 24.38 |
EPS(TTM)1.7
EY2.55%
EPS(NY)2.63
Fwd EY3.94%
FCF(TTM)1.46
FCFY2.18%
OCF(TTM)2.52
OCFY3.78%
SpS10.97
BVpS6.56
TBVpS6.28
PEG (NY)1.46
PEG (5Y)1.34
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.8% | ||
| ROE | 22.21% | ||
| ROCE | 18.43% | ||
| ROIC | 14.52% | ||
| ROICexc | 53.56% | ||
| ROICexgc | 59.66% | ||
| OM | 17.22% | ||
| PM (TTM) | 13.29% | ||
| GM | 60.01% | ||
| FCFM | 13.27% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
ROICexc(3y)35.45%
ROICexc(5y)29.66%
ROICexgc(3y)40.94%
ROICexgc(5y)33.19%
ROCE(3y)14.28%
ROCE(5y)11.73%
ROICexcg growth 3Y55.18%
ROICexcg growth 5Y18.96%
ROICexc growth 3Y50.14%
ROICexc growth 5Y16.58%
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
F-Score6
Asset Turnover0.59
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 4.38 | ||
| Debt/EBITDA | 1.33 | ||
| Cap/Depr | 176.58% | ||
| Cap/Sales | 9.69% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 101.12% | ||
| Profit Quality | 99.88% | ||
| Current Ratio | 1.52 | ||
| Quick Ratio | 1.35 | ||
| Altman-Z | 4.85 |
F-Score6
WACC7.96%
ROIC/WACC1.82
Cap/Depr(3y)175.34%
Cap/Depr(5y)240.83%
Cap/Sales(3y)9.32%
Cap/Sales(5y)10.84%
Profit Quality(3y)97.76%
Profit Quality(5y)73.64%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.86%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%11.63%
EPS Next Y26.84%
EPS Next 2Y26.2%
EPS Next 3Y24.65%
EPS Next 5Y22.6%
Revenue 1Y (TTM)9.3%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%15.21%
Revenue Next Year14.99%
Revenue Next 2Y15.17%
Revenue Next 3Y14.81%
Revenue Next 5Y13.9%
EBIT growth 1Y6.1%
EBIT growth 3Y30.52%
EBIT growth 5Y33.11%
EBIT Next Year77.25%
EBIT Next 3Y38.83%
EBIT Next 5Y31.4%
FCF growth 1Y22.49%
FCF growth 3Y127.88%
FCF growth 5Y36.21%
OCF growth 1Y28.04%
OCF growth 3Y30.77%
OCF growth 5Y25.76%